DCI Partners Co. Ltd. — Full Portfolio
2 tracked investments · listed companies and verified rows first
LUCA Science develops mitochondrial therapies that supply functional, storable mitochondria to damaged or dysfunctional cells and tissues to restore cellular energy production, targeting conditions such as ischemia-reperfusion injuries including cerebral and myocardial infarction.
BiotechDeep TechHealthtechLongevity
Co-investorsAsahi Kasei Corporate Venture CapitalFast Track InitiativeRemiges Ventures, Inc.4BIO CapitalAstellas Venture Management LLCAxil Capital
AI Medical Service Inc. develops AI systems that support image-based diagnosis of endoscopy, primarily for detecting gastrointestinal cancers such as stomach and esophageal cancer.
AI & Machine LearningDigital HealthHealthtechMedical DevicesTokyo, JP
Tomohiro Tada(Representative Director & Chief Medical Officer)inYasushi Takikawa(Representative Director)
Co-investorsGlobis Capital PartnersWiLJapan Post Capital Co. Ltd.SoftBank Vision FundSony Ventures Corporation
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




